|
⚲
|
| Keyboard |
| Spangler Patrick D
✚
|
|
|---|---|
| CIK # | 0001296525 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001296525] | |
| 4 | [0001296525] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Spangler Patrick D | |
| Urologix Inc | |
| Epocrates Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2025-06-11 | Grant | 9,868 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-06-07 | Grant | 13,286 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-06-05 | Option exercise | 10,061 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2024-06-05 | Option exercise | 10,061 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2023-06-07 | Option exercise | 4,637 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-06-07 | Option exercise | 4,637 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-06-07 | Grant | 10,061 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2023-03-31 | Option exercise | 657 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2023-03-31 | Option exercise | 657 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2022-12-30 | Option exercise | 409 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2022-12-30 | Option exercise | 409 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2022-09-29 | Option exercise | 334 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2022-09-29 | Option exercise | 334 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2022-06-09 | Grant | 4,637 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2022-03-30 | Grant | 657 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2021-12-30 | Grant | 409 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock (pursuant to 10B5-1 plan)
|
2021-11-11 | Sell | 6,252 | $84.38 | 527,544 |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2021-09-29 | Grant | 334 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2021-06-30 | Grant | 407 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2021-03-31 | Grant | 539 | $0.00 | |
| showing 20 of 35 most recent transactions | |||||